» Authors » Ebunoluwa E Otegbeye

Ebunoluwa E Otegbeye

Explore the profile of Ebunoluwa E Otegbeye including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 26
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bauer P, Gamboa A, Otegbeye E, Chapman Jr W, Rivard S, Regenbogen S, et al.
J Surg Oncol . 2024 Oct; PMID: 39400312
Background And Objectives: The RAPIDO trial showed promising rates of pathologic complete response (pCR) after neoadjuvant short-course radiation with consolidation chemotherapy (total neoadjuvant therapy [SC TNT]) for rectal cancer. Only...
2.
Han Y, Otegbeye E, Stoll C, Hardi A, Colditz G, Toriola A
Breast Cancer Res . 2024 Mar; 26(1):39. PMID: 38454466
Early life factors are important risk factors for breast cancer. The association between weight gain after age 18 and breast cancer risk is inconsistent across previous epidemiologic studies. To evaluate...
3.
Bauer P, Gamboa A, Otegbeye E, Chapman W, Rivard S, Regenbogen S, et al.
J Surg Oncol . 2023 Oct; 129(2):254-263. PMID: 37792637
Background And Objectives: Neoadjuvant short-course radiation and consolidation chemotherapy (SC TNT) remains less widely used for rectal cancer in the United States than long-course chemoradiation (LCRT). SC TNT may improve...
4.
Fritz C, Otegbeye E, Zong X, Demb J, Nickel K, Olsen M, et al.
J Natl Cancer Inst . 2023 May; 115(8):909-916. PMID: 37138415
Background: Prompt detection of colorectal cancer (CRC) among individuals younger than age 50 years (early-onset CRC) is a clinical priority because of its alarming rise. Methods: We conducted a matched...
5.
Chin R, Otegbeye E, Kang K, Chang S, McHenry S, Roy A, et al.
JAMA Netw Open . 2022 Feb; 5(2):e2146312. PMID: 35103791
Importance: Short-course radiotherapy and total neoadjuvant therapy (SCRT-TNT) followed by total mesorectal excision (TME) has emerged as a new treatment paradigm for patients with locally advanced rectal adenocarcinoma. However, the...
6.
Otegbeye E, Colditz G, Cao Y
JNCI Cancer Spectr . 2021 May; 5(3). PMID: 34041439
No abstract available.
7.
Otegbeye E, Chapman Jr W, Bauer P, Smith R, Glasgow S, Wise P, et al.
J Am Coll Surg . 2020 Dec; 232(4):451-459. PMID: 33383215
Background: Patient-Reported Outcomes Measurement Information System (PROMIS) physical function (PF) is a validated tool for capturing a patient's perception of their physical capacity. The goal of this study was to...
8.
Otegbeye E, Mitchem J, Park H, Chaudhuri A, Kim H, Mutch M, et al.
Transl Res . 2020 Dec; 231:124-138. PMID: 33307273
Rectal cancer remains a challenging disease to treat. Therapy for locally advanced rectal cancer (LARC), the most frequent presentation, has evolved to include a multimodal approach of radiation, chemotherapy, and...